Portland, Oregon, October 23, 2019 – Riverpoint Medical (“Riverpoint” or the “Company”), a Portland, OR-based developer, designer, and manufacturer of medical devices focused on advanced surgical fiber implants and related technologies is pleased to announce the appointment of Doug J. King as Chief Executive Officer. Mr. King most recently served as President of Medtronic’s Spinal business, leading the multi-billion dollar division within Medtronic’s Restorative Therapies Group. With more than 30 years of medical device industry expertise, Mr. King brings a wealth of experience and insight into the fast growing markets that Riverpoint serves.
“The Riverpoint team has built an outstanding business focused on developing and manufacturing polymer-based, advanced medical device products in the rapidly expanding sports medicine, animal health and regenerative end markets. I am excited by the opportunity to partner with Riverpoint and Arlington Capital Partners to accelerate the Company’s growth and build on the strong momentum the team has cultivated since founding the business,” Mr. King said.
Pat Ferguson, who has served as CEO since Riverpoint’s founding will remain highly involved with Riverpoint’s customer driven focus, and continue as a member of the Board of Directors, “I am proud to have founded and helped grow Riverpoint into the Company it has become today. This could not have been done without a lot of hard work and determination from all of the founders and team members. The Riverpoint and Arlington partnership will continue to focus its efforts on high quality, innovative, and advanced technologies that help improve the quality of life.” said Pat Ferguson.
Matt Altman, a Managing Partner at Arlington Capital Partners, said “Doug is a leading executive in the medical device world and we are thrilled to have him join Riverpoint. We look forward to working with him to accelerate Riverpoint’s growth as we enter new markets and expand our existing offerings.”
About Riverpoint Medical
Headquartered in Portland, Oregon, Riverpoint Medical is a leading US-based developer, designer, and manufacturer of medical devices focused on advanced surgical fiber implants and related technologies. Riverpoint’s wound closure products include a broad portfolio of high-quality bio-absorbable and non-absorbable sutures for the surgical and animal health markets. The Company’s robust sports medicine offering includes implants and high strength fiber solutions utilizing its proprietary ultra-high molecular weight polyethylene (UHMWPE) non-absorbable suture (HS Fiber®). Additionally, Riverpoint is a leading provider of cordless LED surgical headlights (MedLED®) and offers a suite of brachytherapy products for the oncology market. www.rpmed.com.
825 NE 25th Avenue
Portland, OR, 97232
About Arlington Capital Partners
Arlington Capital Partners is a Washington, DC-based private equity firm that is currently investing out of Arlington Capital Partners V, L.P., a $1.7 billion fund. The firm has managed approximately $4.0 billion of committed capital via five investment funds. Arlington is focused on middle market investment opportunities in growth industries including healthcare, government services and technology, aerospace & defense, and business services and software. The firm’s professionals and network have a unique combination of operating and private equity experience that enable Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their company’s position as leading competitors in their field. www.arlingtoncap.com.
Matt Altman & Gordon Auduong
Arlington Capital Partners
5425 Wisconsin Avenue, Suite 200
Chevy Chase, MD 20815
SOURCE: Arlington Capital Partners